Hartford Investment Management Co (HIMCO)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.45M Sell
5,538
-214
-4% -$146K 0.1% 184
2026
Q1
$4.44M Sell
5,752
-69
-1% -$52.8K 0.14% 132
2025
Q4
$4.49M Sell
5,821
-143
-2% -$97.1K 0.13% 129
2025
Q3
$3.35M Sell
5,964
-292
-5% -$165K 0.1% 177
2025
Q2
$3.28M Sell
6,256
-162
-3% -$90.4K 0.1% 176
2025
Q1
$4.07M Sell
6,418
-85
-1% -$58.5K 0.14% 138
2024
Q4
$4.63M Sell
6,503
-183
-3% -$154K 0.15% 122
2024
Q3
$7.03M Sell
6,686
-114
-2% -$127K 0.23% 84
2024
Q2
$7.15M Sell
6,800
-28
-0.4% -$27.1K 0.25% 81
2024
Q1
$6.57M Sell
6,828
-391
-5% -$372K 0.23% 93
2023
Q4
$6.34M Sell
7,219
-96
-1% -$79.1K 0.24% 94
2023
Q3
$6.02M Sell
7,315
-295
-4% -$232K 0.24% 89
2023
Q2
$5.47M Sell
7,610
-1,483
-16% -$1.14M 0.21% 104
2023
Q1
$7.47M Sell
9,093
-1,680
-16% -$1.27M 0.25% 91
2022
Q4
$7.77M Sell
10,773
-57
-0.5% -$42.1K 0.24% 88
2022
Q3
$7.46M Sell
10,830
-25
-0.2% -$15.7K 0.24% 88
2022
Q2
$6.42M Buy
10,855
+254
+2% +$165K 0.2% 111
2022
Q1
$7.4M Sell
10,601
-654
-6% -$414K 0.19% 107
2021
Q4
$7.11M Buy
11,255
+905
+9% +$556K 0.16% 126
2021
Q3
$6.26M Sell
10,350
-1,954
-16% -$1.21M 0.17% 123
2021
Q2
$6.87M Sell
12,304
-124
-1% -$62.8K 0.17% 125
2021
Q1
$5.88M Sell
12,428
-198
-2% -$96.4K 0.15% 139
2020
Q4
$6.1M Buy
12,626
+1,658
+15% +$895K 0.16% 132
2020
Q3
$6.14M Buy
10,968
+25
+0.2% +$15.2K 0.21% 105
2020
Q2
$6.83M Buy
10,943
+2,279
+26% +$1.29M 0.24% 91
2020
Q1
$4.23M Buy
8,664
+331
+4% +$137K 0.15% 164
2019
Q4
$3.13M Sell
8,333
-223
-3% -$75K 0.08% 238
2019
Q3
$2.37M Buy
8,556
+5
+0.1% +$1.48K 0.07% 289
2019
Q2
$2.68M Buy
8,551
+66
+0.8% +$22K 0.07% 273
2019
Q1
$3.48M Sell
8,485
-44
-0.5% -$18.1K 0.1% 216
2018
Q4
$3.19M Sell
8,529
-53
-0.6% -$19.4K 0.1% 197
2018
Q3
$3.47M Sell
8,582
-142
-2% -$54K 0.1% 216
2018
Q2
$3.01M Sell
8,724
-5,863
-40% -$1.83M 0.09% 235
2018
Q1
$5.02M Sell
14,587
-1,223
-8% -$425K 0.1% 239
2017
Q4
$5.94M Sell
15,810
-662
-4% -$268K 0.11% 227
2017
Q3
$7.37M Sell
16,472
-15
-0.1% -$7.14K 0.14% 188
2017
Q2
$8.1M Sell
16,487
-509
-3% -$223K 0.16% 162
2017
Q1
$6.59M Sell
16,996
-1,157
-6% -$429K 0.12% 198
2016
Q4
$6.66M Buy
18,153
+59
+0.3% +$22.4K 0.13% 204
2016
Q3
$7.27M Sell
18,094
-315
-2% -$126K 0.15% 172
2016
Q2
$6.43M Sell
18,409
-406
-2% -$156K 0.14% 183
2016
Q1
$6.78M Buy
18,815
+127
+0.7% +$52.3K 0.14% 172
2015
Q4
$10.1M Sell
18,688
-607
-3% -$329K 0.22% 110
2015
Q3
$8.97M Buy
19,295
+627
+3% +$337K 0.2% 122
2015
Q2
$9.52M Buy
18,668
+721
+4% +$352K 0.19% 131
2015
Q1
$8.1M Sell
17,947
-813
-4% -$345K 0.16% 152
2014
Q4
$7.7M Sell
18,760
-368
-2% -$145K 0.15% 155
2014
Q3
$6.9M Sell
19,128
-2,153
-10% -$722K 0.15% 163
2014
Q2
$6.01M Buy
21,281
+31
+0.1% +$9.19K 0.13% 195
2014
Q1
$6.38M Sell
21,250
-261
-1% -$80.4K 0.13% 182
2013
Q4
$5.92M Sell
21,511
-1,257
-6% -$362K 0.12% 194
2013
Q3
$7.12M Sell
22,768
-439
-2% -$115K 0.15% 158
2013
Q2
$5.22M Buy
+23,207
New +$5.4M 0.12% 206

Other funds holding REGN

Hartford Investment Management Co (HIMCO)'s REGN Position: Q2 2026 in Review

Hartford Investment Management Co (HIMCO) reduced its Regeneron Pharmaceuticals (REGN) stake by 3.7% in Q2 2026, selling an estimated $146K and leaving 5,538 shares worth $3.45M. The position accounts for 0.1% of the portfolio, ranked #184.

Hartford Investment Management Co (HIMCO) first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.1M in Q4 2015. 519 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Hartford Investment Management Co (HIMCO) held 5,538 shares of Regeneron Pharmaceuticals worth $3.45M as of Q2 2026.
  • Hartford Investment Management Co (HIMCO) sold 214 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $146K.
  • Regeneron Pharmaceuticals made up 0.1% of Hartford Investment Management Co (HIMCO)'s portfolio in Q2 2026, its #184 holding.
  • Hartford Investment Management Co (HIMCO) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Hartford Investment Management Co (HIMCO)'s Regeneron Pharmaceuticals position peaked at $10.1M in Q4 2015.
  • 519 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q2 2026, filed 15 Jul 2026.